Reading XRAY? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track XRAY free→Reading XRAY? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track XRAY free→QuarterlyIQ Insights · XRAY
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On June 1, 2026, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed John C. Fortson as the Company’s Executive Vice President & Chief Financial Officer, effective as of July 20, 2026 (the “Effective Date”). Mr. Fortson, age 58, currently serves as the President and Chief Financial Officer of Kymera International (…
Results of Operations and Financial Condition On May 5, 2026, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its first fiscal quarter ended March 31, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 and an updated GAAP to Non-GAAP reconciliation is furnished as Exhibit 99.2. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1 and 99.2, shall not be deemed “…
Results of Operations and Financial Condition On February 26, 2026, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its fourth fiscal quarter and year ended December 31, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1. The information contained in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act o…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On February 23, 2026, upon the recommendation of the Corporate Governance and Nominating Committee (the “Governance Committee”) of the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”), and in accordance with the Company’s By-laws, the Board approved an increase in the number of directors from 11 to 13. Also on February 23, 20…
Other Events On October 14, 2025, DENTSPLY SIRONA Inc. (the “Company”) announced that the Division of Enforcement of the Securities and Exchange Commission (the “SEC”) has concluded its investigation of the Company commenced in May 2022 (the “SEC Investigation”) and does not intend to recommend any enforcement action against the Company. The SEC Investigation related to the Company’s investigation led by the Audit and Finance Committee, initiated in March 2022, into allegations regarding cert…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 2, 2025, DENTSPLY SIRONA Inc. (the “Company”) announced that Richard C. Rosenzweig, Executive Vice President, Corporate Development, General Counsel and Secretary of the Company, will no longer serve in that role by mutual agreement, effective October 3, 2025. Mr. Rosenzweig will serve as a non-executive employee with the title of Special…
Importance-ranked changes since the prior daily snapshot.
Confidence changed from 'medium' to 'high'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.